Go Symbol Lookup
Loading...

Stocks Rebound to Close Modestly Lower; HP Surges 17%

Ross Stores, Alexion Stock Compared

 Text Size  
Published: Wednesday, 4 Jan 2012 | 7:26 PM ET
By:

Producer

Cramer's NASDAQ Playoff: ALXN vs. ROST
Mad Money's Cramer pits two of the best performing NASDAQ stocks: Alexion Pharmaceuticals and Ross Stores, against each other to determine which is the better play.

On Wednesday, Cramer compared two stocks: Ross Stores and Alexion Pharmaceuticals . Both stocks were among the winners of the Nasdaq last year.

Alexion is a biotechnology firm that develops “orphan drugs,” which are basically drugs that get special exclusivity rights from the government because they treat very rare diseases. Ross Stores is the second-largest off-price retailer in the United States.

Both stocks performed well last year, but Cramer thinks Alexion is the one to bet on going forward. He thinks the company is more likely to be taken over and has many new products coming down the pipeline.





  Price   Change %Change
530985 ---
ROST ---

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

 Print
Cramer reveals which he prefers going forward.
  Price   Change %Change
ALXN ---
ROST ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p | 11p ET
  • Cramer is host of CNBC's "Mad Money," and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.